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Abstract Resting skeletal muscle has a preference for the
oxidation of lipids compared to carbohydrates and a shift
towards carbohydrate oxidation is observed with increasing
exercise. Lactate is not only an end product in skeletal
muscle but also an important metabolic intermediate for
mitochondrial oxidation. Recent advances in hyperpolar-
ized MRS allow the measurement of substrate metabolism
in vivo in real time. The aim of this study was to investigate
the use of hyperpolarized 13C lactate as a substrate for
metabolic studies in skeletal muscle in vivo. Carbohydrate
metabolism in healthy rat skeletal muscle at rest was
studied in different nutritional states using hyperpolarized
[1-13C]lactate, a substrate that can be injected at physio-
logical concentrations and leaves other oxidative processes
undisturbed. 13C label incorporation from lactate into
bicarbonate in fed animals was observed within seconds but
was absent after an overnight fast, representing inhibition of
the metabolic flux through pyruvate dehydrogenase (PDH).
A significant decrease in 13C labeling of alanine was
observed comparing the fed and fasted group, and was
attributed to a change in cellular alanine concentration and
not a decrease in enzymatic flux through alanine transam-
inase. We conclude that hyperpolarized [1-13C]lactate can
be used to study carbohydrate oxidation in resting skeletal
muscle at physiological levels. The herein proposed method
allows probing simultaneously both PDH activity and
variations in alanine tissue concentration, which are asso-
ciated with metabolic dysfunctions. A simple alteration of
the nutritional state demonstrated that the observed pyru-
vate, alanine, and bicarbonate signals are indeed sensitive
markers to probe metabolic changes in vivo.
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1 Introduction
To meet its energy demands resting skeletal muscle has a
preference for the oxidation of lipids compared to that of
carbohydrates but with increasing exercise intensity, a fuel
shift is observed from lipid towards carbohydrate utiliza-
tion and during intense exercise nearly 100 % of oxidative
capacity is used for the oxidation of carbohydrates (Brooks
and Mercier 1994; Brooks 1998). Lactate concentrations in
skeletal muscle and plasma are known to increase during
exercise, and skeletal muscle is a major producer of lactic
acid in the body.
However, lactate is not only the product of anaerobic
metabolism but also a source of pyruvate, and resting
skeletal muscle is even viewed as the most likely primary
consumer of lactic acid as a respiratory fuel (Gladden
2004; Roth 1991; Brooks 2000). Lactate enters the cell via
monocarboxylate transporters and by free diffusion at
higher concentrations ([10 mM) (Poole and Halestrap
1993; Juel 1991). Changes in cellular lactate concentrations
are affected by the cytosolic redox potential, thus affecting
production and utilization of pyruvate. In the cytosol it is
transformed into pyruvate by lactate dehydrogenase (LDH)
and pyruvate is converted to alanine via alanine transam-
inase (ALT) (Fig. 1). Pyruvate is shuttled into the mito-
chondria and transformed via pyruvate dehydrogenase
(PDH) into acetylCoA, a key entry molecule for the tri-
carboxylic acid (TCA) cycle. The flux through PDH also
results in the formation of CO2 which equilibrates with
bicarbonate. These aforementioned metabolic pathways
can be studied using 13C magnetic resonance spectroscopy
(MRS), and lactate, being a simple carbohydrate, has pre-
viously been used as a substrate for carbohydrate metab-
olism in resting skeletal muscle and was shown to be
readily oxidized (Bertocci et al. 1997; Bertocci and Lujan
1999).
Only the most abundant metabolites can be detected
by conventional 13C MRS in vivo. Recent developments
in hyperpolarized 13C MRS allow for the detection of
less abundant metabolites by increasing the signal-to-
noise ratio by several orders of magnitude (Ardenkjaer-
Larsen et al. 2003). However, pyruvate, which has been
the most widely used substrate for hyperpolarized 13C
studies of carbohydrate metabolism, has some disadvan-
tages. Hyperpolarized pyruvate administration results in
supraphysiological levels and pyruvate also influences
the oxidation of other metabolic substrates. Excess
pyruvate of *10 mM inhibits the oxidation of palmitate
as well as lactate (Yoshida et al. 2007). Conversely,
*10 mM excess lactate fails to inhibit the oxidation of
palmitate and pyruvate (Yoshida et al. 2007) and does
not influence the uptake of glucose, alanine output, or
the glycogen store up to *30 mM (Gladden et al. 1994).
Lactate does not influence the metabolism of other
substrates, and endogenous lactate exceeds cytosolic
pyruvate concentrations by an order of magnitude.
Another benefit of using lactate as a hyperpolarized 13C
substrate is that the formation and detection of the
pyruvate resonance can be used directly as a marker of
the intracellular 13C concentration. This can be used as a
reference for scaling the signals of the downstream
metabolites alanine and bicarbonate, which then become
independent of the initial polarization level. The appli-
cability of hyperpolarized [1-13C]lactate as a metabolic
substrate has recently been demonstrated (Chen et al.
2008) and was used to measure the activity of LDH in
tumors (Kennedy et al. 2012) and changes in the flux
through PDH in hearts subjected to dichloroacetate
treatment (Mayer et al. 2012). The aim of this study was
to explore the use of hyperpolarized [1-13C]lactate as a
suitable probe for investigating carbohydrate oxidation in
skeletal muscle in vivo. To determine the sensitivity of
hyperpolarized lactate metabolism to metabolic changes,
two nutritional situations were studied: the fed and fasted
states.
Fig. 1 Scheme of [1-13C]lactate metabolism in skeletal muscle
in vivo. The 13C label propagation is indicated by the bold arrows
and metabolites observed following [1-13C]lactate oxidation are in
bold typeface. Lactate enters the cell through MCT transporters and is
converted to pyruvate by LDH. Pyruvate is transformed by ALT to
alanine via a reversible transamination reaction. Pyruvate in turn can
enter the mitochondria via PDH resulting in acetylCoA and
bicarbonate. ALT Alanine transaminase; LDH lactate dehydrogenase;
PDH pyruvate dehydrogenase; TCA tricarboxylic acid cycle; MCT
monocarboxylate transporter; CA carbonic anhydrase; PT pyruvate
transporter
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2 Materials and methods
2.1 Samples preparation and hyperpolarization
protocol
Sodium [1-13C]lactate and TEMPOL nitroxyl radicals were
obtained from Sigma Aldrich (Buchs, Switzerland).
Sodium [1-13C]lactate was mixed with d8-glycerol in a 2:1
weight ratio to a concentration of 4.0 M with a final radical
concentration of 50 mM. The solutions were rapidly frozen
in liquid nitrogen to form 2 ± 0.5 lL beads that were
inserted into a sample cup which was further cooled to
1 ± 0.05 K in a 7 T custom-designed DNP polarizer
(Comment et al. 2007), where the 13C nuclei were
dynamically polarized with microwave irradiation
(197.25 MHz and 55 mW) for 90 min, with a buildup time
of 60 min. Using an automated process, the sample was
rapidly dissolved using 6.0 mL of pressurized, heated D2O
and transferred within 2 s following dissolution to a sep-
arator/infusion pump, containing 0.6 mL of PBS and hep-
arin, located inside a 9.4 T horizontal bore magnet (Cheng
et al. 2013; Comment et al. 2007). Subsequently, 1.5 mL of
the hyperpolarized solution at physiological temperature
and pH was automatically infused into the animal during
8 s. The 13C polarization level at the time of the injection
was 17 ± 2 %.
2.2 Animals
All animal studies conformed to institutional guidelines.
Wild type male Sprague–Dawley rats (293 ± 19 g) were
anesthetized with 1.5 % isoflurane in oxygen. A catheter
was placed into the femoral vein for intravenous delivery
of the hyperpolarized solution. A second catheter was
placed in the artery to monitor the blood pressure, to
measure glucose and lactate concentrations, pH, PCO2,
PO2 and bicarbonate concentrations. Plasma samples
were taken before the experiment, right after the hyper-
polarized [1-13C]lactate injection and at 5–10 min inter-
vals thereafter. The respiration rate and temperature were
monitored and maintained constant during the experi-
ment. Two groups of animals were studied, fed animals
(n = 5) and fasted animals (n = 5). The animals in the
fasted group were fasted overnight by placing them in a
clean cage without food the evening before the experi-
ment, starting at around 5 pm. This resulted in a fasting
period of about 16 h. All animal experiments were per-
formed in the morning. Each animal was injected three
times consecutively with [1-13C]hyperpolarized lactate.
The lactate injections did not significantly change the
physiology of the animal in terms of pH, PCO2, PO2,
bicarbonate and glucose levels (Supplemental Table 1).
Lactate concentration changes are described in the results
section.
2.3 In vivo magnetic resonance spectroscopy
Measurements were carried out on a 9.4 T/31 cm actively
shielded animal scanner (Varian/Magnex). A custom-made
radiofrequency (RF) hybrid probe consisting of a 10 mm
diameter 13C surface coil and two 10 mm diameter 1H
surface coils placed in quadrature was positioned over the
hind leg of the rat for transmission and reception, localiz-
ing the signals from the skeletal muscle. Acquisition of
gradient echo proton images confirmed the correct position
of the coils to probe the gastrocnemius muscles. Shimming
was performed to reduce the localized proton line width in
a voxel of 6 9 10 9 10 mm to 20–30 Hz using FAST-
ESTMAP (Gruetter and Tkac 2000). The NMR console
was triggered to start acquisition at the beginning of the
automated injection process, 6 s after dissolution of the
hyperpolarized sample. Series of single pulse acquisitions
were recorded using 30 adiabatic RF pulses (BIR-4)
applied every 3 s with 1H decoupling using WALTZ-16.
Typically 40–60 FIDs were acquired with 4,129 complex
data points over a 20,000 Hz bandwidth. The adiabatic
pulse offset and power were calibrated to ensure a 30
excitation pulse for all observed metabolites in the entire
tissue of interest. Following data acquisition, 200 lL liquid
samples were extracted from the separator/infusion pump
to precisely determine the infused [1-13C]lactate concen-
tration using a high-resolution 400 MHz MR spectrometer
(Bruker, Fa¨llanden, Switzerland).
2.4 Metabolite extraction and NMR spectroscopy
Wild type male Sprague–Dawley rats (n = 6) were anes-
thetized with 1.5 % isoflurane in oxygen. They were divided
in two groups, either fed or fasted overnight. Metabolite
extraction and 1H spectroscopy was performed as described
in (Duarte et al. 2007). In brief, skeletal muscle tissue was
excised, placed immediately in liquid nitrogen and stored at
-80 C until extraction. Water-soluble metabolites were
extracted with 7 % (v/v) perchloric acid (PCA) and dried
with a sample concentrator (SpeedVac DNA 120, Thermo
Fisher Scientific, Wohlen, Switzerland). The dried extracts
were dissolved in D2O (99.9 % D, Sigma-Aldrich) and
1.2 mmol sodium fumarate (Sigma-Aldrich) was added as
internal standard for quantification by 1H NMR spectros-
copy. 1H NMR spectra were acquired on a 14.1 T DRX-600
spectrometer equipped with a 5-mm cryoprobe (Bruker
BioSpin SA, Fa¨llanden, Switzerland) to determine alanine
concentrations in the tissue samples. Peak areas were
quantified by curve fitting in jMRUI.
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2.5 Data analysis
The resonance peaks of the infused substrates and their
corresponding metabolic products were assigned according
to their chemical shifts. 13C NMR time courses were
summed for the time period during which the hyperpolar-
ized [1-13C]lactate resonance had a signal-to-noise ratio
higher than 5 (typically 16 spectra satisfied that criterion).
On average this corresponds to the time interval from 9 to
57 s after the injection, in both animal groups. The
resulting summed spectra were fitted to Lorentzian line
shapes using Bayesian analysis (Bretthorst 1990). These
summed integrals were used to determine the ratios of one
substrate relative to the other. Metabolite time courses
were obtained by applying a 10 Hz line broadening on the
raw data, followed by fitting in jMRUI (Naressi et al.
2001). Statistical differences between the ratios of
observed metabolites were calculated using a two-tailed
t test for unpaired data with equal variance. Error bars in
figures and in the manuscript indicate ± standard error of
the mean (SEM) unless otherwise indicated.
3 Results
Carbohydrate metabolism was studied in healthy resting
skeletal muscle in vivo in fed and fasted animals using
hyperpolarized [1-13C]lactate. Overnight fasting resulted
in a 30 % decrease in plasma glucose and a 41 %
decrease in plasma lactate compared with animals which
were fed ad libitum (Table 1). Lactate metabolism was
detected in the skeletal muscle of healthy rats in vivo
(n = 10) and the following metabolite resonances were
observed: [1-13C]pyruvate (171.2 ppm), [1-13C]alanine
(177.0 ppm) and 13C bicarbonate (161.3 ppm). The
spectral time courses of fed animals injected with hyper-
polarized [1-13C]lactate showed (Fig. 2a) that within
seconds, lactate was transformed into pyruvate in the
cytosol. The 13C MR signal of the [1-13C]lactate reso-
nance increased due to perfusion of the substrate into the
tissue, and decayed with time as a consequence of a
combination of the loss of spin polarization related to the
longitudinal relaxation time, the loss of longitudinal
magnetization due to repeated RF excitations and the
metabolic conversion of lactate to its downstream
metabolites. The 13C MR signal of the other metabolites
increased due to metabolic conversion, and decreased due
to repeated RF excitations and relaxation processes.
Although in principle these parameters need to be taken
into account to obtain quantitative measures of kinetic
rate constants by means of mathematical modeling, it was
shown that kinetic rates obtained from the mathematical
modeling of metabolite time courses are directly
proportional to calculated metabolite ratios (Bastiaansen
et al. 2013).
The observation of bicarbonate in summed spectra
(Fig. 2b) indicates that part of the labeled pyruvate was
transported into the mitochondrion for subsequent oxidation in
the TCA cycle. The time evolution of the signal integrals of
lactate, alanine, pyruvate and bicarbonate (Fig. 3) show that
alanine attained higher signal intensities compared to pyruvate
but the maximum was reached at a later time point compared
with pyruvate in all experiments. On average, alanine reached
its maximum at 28 ± 4 s and pyruvate at 22 ± 4 s in the fed
state (±standard deviation). In the fasted state, the maximum
for alanine was reached at 28 ± 3 s and for pyruvate at
22 ± 2 s. There were no significant differences in the time to
maximum for both metabolites in both metabolic states. The
linewidths of detected 13C resonances were on average 22 Hz.
The injected lactate concentration was between 100 and
250 mM. After a rapid elevation to 8.2 ± 1.5 mM following
the delivery of the hyperpolarized solution, the arterial lactate
concentration returned to its baseline level within 20 min
(Supplemental Figure 1). The resonance of 13C bicarbonate
was absent in animals which were fasted overnight (n = 5). In
the fed group (n = 5), bicarbonate was only detected in nine
out of fifteen experiments because of the low SNR in experi-
ments with lower lactate dose. In both groups, the same rela-
tionship was observed between the SNR of the lactate signal
and the injected dose.
Spectra were summed according to the criteria men-
tioned in the Methods section and there was no significant
shift in the time interval used for summing between the fed
and fasted state. The summed signals were expressed rel-
ative to [1-13C]lactate, and also to the two other intracel-
lular 13C enriched metabolites, namely [1-13C]pyruvate and
[1-13C]alanine. These ratios are independent of variations
in the initial polarization level of [1-13C]lactate. Compar-
ing fed and fasted states, the bicarbonate signal was
undetectable in the fasted group (p \ 0.0005), whereas the
ratio of bicarbonate to lactate in the fed group was
0.0029 ± 0.0005 (Fig. 4a). The ratio of bicarbonate rela-
tive to pyruvate was 0.10 ± 0.02 (Fig. 4c) and the ratio
relative to alanine 0.04 ± 0.01. The ratio of pyruvate to
lactate increased marginally from 0.030 ± 0.002 to
0.034 ± 0.002 (p \ 0.2, Fig. 4a) and alanine decreased
significantly from 0.072 ± 0.004 to 0.058 ± 0.004 when
comparing fed with fasted animals (p \ 0.05, Fig. 4a). The
Table 1 Plasma glucose and lactate concentrations in fed and over-
night fasted animals with ± standard deviation
Plasma concentration Fed Fasted
Lactate (mM) 2.1 ± 0.2 1.3 ± 0.1
Glucose (mM) 8.2 ± 1.0 5.7 ± 0.5
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ratio of pyruvate to alanine increased significantly
(p \ 0.005) by 42 % from 0.43 ± 0.03 to 0.61 ± 0.04
(Fig. 4b).
The influence of the injected lactate dose on the for-
mation of bicarbonate, alanine and pyruvate was also
investigated: The metabolite ratios were compared to
the administered lactate dose and no relationship was
observed. There was no influence of repeated lactate
injections in the same animal on the ratio of alanine and
bicarbonate relative to pyruvate in the fed and fasted sit-
uation (Supplemental Figure 2).
In a separate set of experiments, animals were either fed
(n = 3) or fasted overnight (n = 3). 1H NMR analysis of
tissue extracts showed a 78 % decrease in alanine pool size
after an overnight fast, from 2.32 ± 0.66 to 0.50 ±
0.27 lmol/g (Table 2).
4 Discussion
In this study, it was shown that hyperpolarized
[1-13C]lactate is rapidly taken up by resting skeletal muscle
Fig. 2 Spectra acquired from
the rat skeletal muscle using 30
adiabatic pulses applied every
3 s after the injection of
hyperpolarized [1-13C]lactate
show the formation of
[1-13C]alanine, [1-13C]pyruvate
and 13C bicarbonate (a). Spectra
shown here were line broadened
with 10 Hz. b Representative
summed spectrum acquired
from rat skeletal muscle in vivo
after hyperpolarized
[1-13C]lactate injection in a fed
(top) and fasted (bottom)
animal. Fifteen spectra were
summed and are displayed using
5 Hz line broadening. Asterisks
The resonance on the shoulder
of alanine observed at
177.5 ppm was attributed to an
impurity in the [1-13C]lactate
solution (b)
Fig. 3 Timecourses of integrated spectra showing the evolution of
the injected hyperpolarized substrate [1-13C]lactate and its down-
stream metabolites pyruvate, alanine and bicarbonate in a fed (a) and
a fasted (b) animal. The hyperpolarized lactate integrals were
fifteenfold downscaled. Spectral acquisition started 6 s after the
dissolution process with a repetition time of 3 s and flip angle of 30
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in vivo and quickly converted to pyruvate for subsequent
oxidation in the mitochondrion. Lactate was chosen since it
can be administered at physiological concentrations leav-
ing other metabolic process undisturbed, unlike pyruvate
(Yoshida et al. 2007; Gladden et al. 1994). In this particular
study, no physiological changes were observed as a result
of the hyperpolarized lactate injection in terms of heart
rate, blood pressure, pH, PCO2, PO2, bicarbonate and
glucose levels (Supplemental Table 1). The metabolic
conversion rate of lactate was however sensitive to a
simple alteration of nutritional state. Significant decreases
in 13C labeling of both bicarbonate and alanine were
observed after an overnight fast. The absence of 13C
bicarbonate signal in the fasted group is a result of the
inhibition of metabolic flux through PDH (Garland et al.
1964; Schroeder et al. 2008). Increases in the acetylCoA/
CoA ratio or the NADH concentration further inhibit PDH.
In general, alanine attained higher 13C signal intensities
compared to pyruvate, as was also observed in the abdo-
men and the rat heart (Mayer et al. 2012; Chen et al. 2008).
This is attributed to the much larger pool size of alanine
compared to pyruvate in both nutritional states (Berger
et al. 1976; Jucker et al. 1997). It also suggests that the
fractional enrichment of the cellular pyruvate pool was
high enough to ensure efficient 13C label transfer into the
cellular alanine pool. Contribution to the signal from sur-
rounding organs was expected to be negligible and has
been previously discussed (Bastiaansen et al. 2013).
It has been shown that, after administration of hyper-
polarized pyruvate or lactate, there is a rapid exchange of
13C label between the pyruvate and lactate pools, and that
observed changes in 13C labeling of lactate and pyruvate is
representative of the metabolite’s pool size at the time of
the measurements rather than originating from a net
enzymatic flux through LDH (Day et al. 2007; Merritt et al.
2007; Kettunen et al. 2010). Since, like LDH, ALT is a
reversible enzyme, fast isotope redistribution between the
pyruvate and alanine pools implies that the variation in
alanine to pyruvate 13C signal ratio is essentially a conse-
quence of changes in the endogenous relative concentra-
tions of both metabolites. The significant reduction of this
ratio observed in fasted fed animals could result from an
increase in pyruvate signal, a decrease in alanine signal or a
combination of both.
An increase in endogenous pyruvate concentration in
the fasted state could be due to inhibition of pyruvate
oxidation (Garland et al. 1964), or due to increased
NAD? levels which shift the LDH-catalyzed reaction
towards the formation of pyruvate (Houtkooper et al.
2010). However, as mentioned above, the slight increase
in pyruvate to lactate 13C signal ratio observed in our
experiments was not statistically significant (p \ 0.2). The
largely significant decrease in alanine to pyruvate 13C
signal ratio observed in the fasted state is thus most likely
mainly a consequence of a decrease of the alanine pool
size.
In previous studies where hyperpolarized [1-13C]pyru-
vate was used as a substrate, a decrease in the 13C alanine
signal was observed in a perfused liver model and in the
liver in vivo after a fasting period and this reduction was
ascribed to a cellular redox state change and a reduction in
ALT activity respectively (Merritt et al. 2011; Hu et al.
2009). However, a direct comparison with results obtained
using pyruvate as a hyperpolarized substrate is challenging
since different metabolite pools are enriched and the
reaction pathways and directions probed are different.
Fig. 4 Signal ratios of pyruvate (a) and bicarbonate (b, c) relative to
lactate and alanine. Spectra were summed over a time interval
between 9 and 57 s after the injection, corresponding to an SNR of
[1-13C]lactate[5. Asterisks denote statistically significant differences
compared to the fed state between metabolite ratios where *p \ 0.05,
**p \ 0.005, ***p \ 0.0005, ****p \ 0.00005
Table 2 Alanine concentrations in skeletal muscle of fed and over-
night fasted rats with ± standard deviation
Tissue concentration Fed (n = 3) Fasted (n = 3)
Alanine (lmol/g) 2.32 ± 0.66 0.50 ± 0.27
Lactate metabolism in skeletal muscle 991
123
Moreover, the liver takes up alanine for gluconeogenic
purposes while the muscle releases it.
There have been reports of decreased skeletal muscle
tissue concentrations of alanine after a 24 h fast (Christop
et al. 1971) and alanine concentrations were also dimin-
ished in overnight fasted animals based on 1H NMR
measurements of tissue extracts in a separate set of
experiments (Table 2). Therefore, a decrease in 13C alanine
labeling can be most likely ascribed to a change in cellular
alanine concentration. The endogenous alanine concentra-
tion is reduced in fasted muscles because of an enhanced
alanine efflux (Macdonald et al. 1976; Felig 1973).
It is known that during fasting conditions and other
situations of negative nitrogen balance, muscle is the major
source of carbon and nitrogen for the synthesis of glucose
and urea in the liver (Ruderman and Berger 1974; Mallette
et al. 1969). In such conditions, amino acid catabolism
increases (Odessey et al. 1974) and alanine is the principal
amino acid released by skeletal muscle. Moreover, it was
shown that the alanine release reflects the rate of de novo
synthesis (Karl et al. 1976), and changes in alanine syn-
thesis and release are related to pyruvate formation from
amino acids (Garber et al. 1976), which increases during
fasting. Although the formation and efflux of alanine is
stimulated during fasting, the decreased hyperpolarized 13C
label transfer to alanine observed in this study is clearly not
only dependent on the enzymatic flux through ALT but
coupled with changes in fractional enrichments, pool sizes
and formation of intermediate substrates. Since these fac-
tors are affected in several diseases, such as in diabetes
where the release of lactate and alanine is increased (Karl
et al. 1976; Berger et al. 1976), ketotic hypoglycemia
where gluconeogenesis is impaired due to insufficient
release of alanine (Pagliara et al. 1972), or maple syrup
urine disease where decarboxylation of amino acids is
impaired and alanine levels are three- to tenfold lower
(Dancis et al. 1960), the alanine-to-pyruvate ratio could be
a sensitive biological marker for the detection of skeletal
muscle metabolic disorders.
The time evolution of the lactate resonance shows a
buildup followed by decay and this is different from
hyperpolarized acetate injections in skeletal muscle using
an identical injection protocol (Bastiaansen et al. 2013).
This difference could be attributed to a different uptake of
both substrates. Acetate enters the cell via concentration
gradient facilitated diffusion while lactate mainly enters via
monocarboxylate transporters and also by free diffusion at
concentrations [10 mM (Poole and Halestrap 1993; Juel
1991). Since the concentrations used in this study were
*8 mM, lactate was assumed to enter the cell largely via
MCT transport.
The hyperpolarized lactate injections resulted in a five-
fold elevation of endogenous lactate (*8 mM) compared
to the resting state. Tissue concentrations of lactate can
increase up to 10–50 mM in a state of exercise and our
injected values are thus within physiological range (Gob-
atto et al. 2001; Watt et al. 1988). Lactate was cleared from
the blood within minutes (Supplemental Figure 1). The
ability to uptake and process lactate at these concentrations
is also reflected by the high KM values for MCT across the
cellular membrane which were found to be between 13 and
40 mM (Juel and Halestrap 1999). MCT1 and MCT4 are
the predominant isoforms expressed in skeletal muscle. No
dose dependencies were observed in the metabolite-to-
lactate ratios, which is indicative of lactate transport being
proportional to blood lactate concentration and in agree-
ment with the higher KM value compared to the lactate
concentrations.
Previous studies in the literature show that after a 24
and a 48 h fast, plasma lactate concentrations decrease but
the concentration of lactate in rat skeletal muscle tissue
remains unchanged (Goodman et al. 1974, 1990). In a
study using overnight fasted rats, a 30 min infusion of
lactate increased plasma lactate levels fourfold but did not
increase the plasma concentrations of free fatty acids and
alanine (Vettor et al. 1997). Infusing lactate up to 30 mM
did not affect glucose uptake, pyruvate uptake/output, and
alanine output in canine skeletal muscle (Gladden et al.
1994). Therefore, we conclude that the observed changes
in 13C label propagation are a likely consequence of an
actual shift in lactate metabolism in skeletal muscle upon
fasting.
5 Conclusions
The significant changes observed in 13C labeling of
bicarbonate and alanine after an overnight fast were
attributed to decreased PDH flux and a decrease in cellular
alanine concentration. We conclude that lactate can be
administered at physiological concentrations without
disturbing other oxidative processes and is readily oxidized
in resting skeletal muscle. Therefore hyperpolarized
[1-13C]lactate is well suited for studying carbohydrate
metabolism in skeletal muscle in vivo. The ratio of alanine
to pyruvate is not only dependent on the enzymatic flux
through ALT, but also on changes in fractional enrichments
and pool size of intermediates. The fact that alanine con-
centration changes can be monitored in vivo using an
endogenous substrate at nearly physiological concentra-
tions will offer the opportunity to probe skeletal muscle
metabolic disorders and to test the efficiency of drugs
targeting specific muscular diseases.
Acknowledgments We would like to thank Tian Cheng and Andrea
Capozzi for their suggestions and improvements on the lactate recipe
992 J. A. M. Bastiaansen et al.
123
and Jacquelina Romero, Laure Bardouillet and Mario Lepore for
veterinary support.
Conflict of interest The authors declare no conflicts of interest.
Animal studies All institutional and national guidelines for the care
and use of laboratory animals were followed.
Funding This work was supported by the Swiss National Science
Foundation (Grant PP00P2_133562 and 31003AB_131087), the
Centre d’Imagerie BioMe´dicale (CIBM) of the UNIL, UNIGE, HUG,
CHUV, EPFL, and the Leenaards and Jeantet Foundations.
References
Ardenkjaer-Larsen, J. H., Fridlund, B., Gram, A., Hansson, G.,
Hansson, L., Lerche, M. H., et al. (2003). Increase in signal-to-
noise ratio of [ 10,000 times in liquid-state NMR. Proceedings
of the National Academy of Sciences of the United States of
America, 100(18), 10158–10163.
Bastiaansen, J. A. M., Cheng, T., Mishkovsky, M., Duarte, J. M. N.,
Comment, A., & Gruetter, R. (2013). In vivo enzymatic activity
of acetylCoA synthetase in skeletal muscle revealed by 13C
turnover from hyperpolarized [1-13C]acetate to [1-13C]acetyl-
carnitine. Biochimica et Biophysica Acta, 1830(8), 4171–4178.
doi:10.1016/j.bbagen.2013.03.023.
Berger, M., Hagg, S. A., Goodman, M. N., & Ruderman, N. B.
(1976). Glucose-metabolism in perfused skeletal-muscle—
Effects of starvation, diabetes, fatty-acids, acetoacetate, insulin
and exercise on glucose-uptake and disposition. Biochemical
Journal, 158(2), 191–202.
Bertocci, L. A., Jones, J. G., Malloy, C. R., Victor, R. G., & Thomas,
G. D. (1997). Oxidation of lactate and acetate in rat skeletal
muscle: Analysis by C-13-nuclear magnetic resonance spectros-
copy. Journal of Applied Physiology, 83(1), 32–39.
Bertocci, L. A., & Lujan, B. F. (1999). Incorporation and utilization
of [3-C-13]lactate and [1,2-C-13]acetate by rat skeletal muscle.
Journal of Applied Physiology, 86(6), 2077–2089.
Bretthorst, G. L. (1990). Bayesian analysis. I: Parameter estimation
using quadrature NMR models. Journal of Magnetic Resonance,
88, 533–551.
Brooks, G. A. (1998). Mammalian fuel utilization during sustained
exercise. Comparative Biochemistry and Physiology B-Biochem-
istry and Molecular Biology, 120(1), 89–107. doi:10.1016/
S0305-0491(98)00025-X.
Brooks, G. A. (2000). Intra- and extra-cellular lactate shuttles.
Medicine and Science in Sports and Exercise, 32(4), 790–799.
doi:10.1097/00005768-200004000-00011.
Brooks, G. A., & Mercier, J. (1994). Balance of carbohydrate and
lipid utilization during exercise: The crossover concept. Journal
of Applied Physiology, 76(6), 2253–2261.
Chen, A. P., Kurhanewicz, J., Bok, R., Xua, D., Joun, D., Zhang, V.,
et al. (2008). Feasibility of using hyperpolarized [1-C-13]lactate
as a substrate for in vivo metabolic C-13 MRSI studies.
Magnetic Resonance Imaging, 26(6), 721–726. doi:10.1016/j.
mri.2008.01.002.
Cheng, T., Mishkovsky, M., Bastiaansen, J. A. M., Ouari, O., Hautle,
P., Tordo, P., et al. (2013). Method to minimize and monitor
in situ the polarization losses in hyperpolarized biomolecules
prior to in vivo MR experiments. NMR in Biomedicine,. doi:10.
1002/nbm.2993.
Christop, J., Winand, J., & Hebbelin, M. (1971). Amino acid levels in
plasma, liver, muscle, and kidney during and after exercise in
fasted and fed rats. American Journal of Physiology, 221(2),
453–457.
Comment, A., van den Brandt, B., Uffmann, K., Kurdzesau, F.,
Jannin, S., Konter, J. A., et al. (2007). Design and performance
of a DNP prepolarizer coupled to a rodent MRI scanner.
Concepts in Magnetic Resonance Part B: Magnetic Resonance
Engineering, 31B(4), 255–269.
Dancis, J., Hutzler, J., & Levitz, M. (1960). Metabolism of the white
blood cells in maple-syrup-urine disease. Biochimica et Biophy-
sica Acta, 43(2), 342–343. doi:10.1016/0006-3002(60)90448-0.
Day, S. E., Kettunen, M. I., Gallagher, F. A., Hu, D. E., Lerche, M.,
Wolber, J., et al. (2007). Detecting tumor response to treatment
using hyperpolarized C-13 magnetic resonance imaging and
spectroscopy. Nature Medicine, 13(11), 1382–1387. doi:10.
1038/Nm1650.
Duarte, J. M., Cunha, R. A., & Carvalho, R. A. (2007). Different
metabolism of glutamatergic and GABAergic compartments in
superfused hippocampal slices characterized by nuclear mag-
netic resonance spectroscopy. Neuroscience, 144(4), 1305–1313.
doi:10.1016/j.neuroscience.2006.11.027.
Felig, P. (1973). The glucose–alanine cycle. Metabolism-Clinical
and Experimental, 22(2), 179–207. doi:10.1016/0026-0495(73)
90269-2.
Garber, A. J., Karl, I. E., & Kipnis, D. M. (1976). Alanine and
glutamine synthesis and release from skeletal-muscle. 2. precur-
sor role of amino-acids in alanine and glutamine synthesis.
Journal of Biological Chemistry, 251(3), 836–843.
Garland, P. B., Randle, P. J., & Newsholme, E. A. (1964). Regulation
of glucose uptake by muscle. 9. Effects of fatty acids ? ketone
bodies ? of alloxan-diabetes ? starvation on pyruvate metabo-
lism ? on lactate/pyruvate ? l-glycerol 3-phosphate/dihydrox-
yacetone phosphate concentration ratios in rat heart ? rat
diaphragm muscles. Biochemical Journal, 93(3), 665–678.
Gladden, L. B. (2004). Lactate metabolism: A new paradigm for the
third millennium. The Journal of Physiology, 558(1), 5–30.
doi:10.1113/jphysiol.2003.058701.
Gladden, L. B., Crawford, R. E., & Webster, M. J. (1994). Effect of
lactate concentration and metabolic-rate on net lactate uptake by
canine skeletal-muscle. American Journal of Physiology, 266(4),
R1095–R1101.
Gobatto, C. A., de Mello, M. A. R., Sibuya, C. Y., de Azevedo, J.
R. M., dos Santos, L. A., & Kokubun, E. (2001). Maximal lactate
steady state in rats submitted to swimming exercise. Compar-
ative Biochemistry and Physiology Part A: Molecular and
Integrative Physiology, 130(1), 21–27. doi:10.1016/S1095-
6433(01)00362-2.
Goodman, M. N., Berger, M., & Ruderman, N. B. (1974). Glucose-
metabolism in rat skeletal-muscle at rest effect of starvation,
diabetes, ketone-bodies and free fatty-acids. Diabetes, 23(11),
881–888.
Goodman, M. N., Dietrich, R., & Luu, P. (1990). Formation of
gluconeogenic precursors in rat skeletal muscle during fasted-
refed transition. American Journal of Physiology, 259(4 Pt 1),
E513–E516.
Gruetter, R., & Tkac, I. (2000). Field mapping without reference scan
using asymmetric echo-planar techniques. Magnetic Resonance
in Medicine, 43(2), 319–323.
Houtkooper, R. H., Canto, C., Wanders, R. J., & Auwerx, J. (2010).
The secret life of NAD(?): An old metabolite controlling new
metabolic signaling pathways. Endocrine Reviews, 31(2),
194–223. doi:10.1210/Er.2009-0026.
Hu, S., Chen, A. P., Zierhut, M. L., Bok, R., Yen, Y. F., Schroeder, M.
A., et al. (2009). In vivo carbon-13 dynamic MRS and MRSI of
normal and fasted rat liver with hyperpolarized C-13-pyruvate.
Molecular Imaging and Biology, 11(6), 399–407. doi:10.1007/
s11307-009-0218-z.
Lactate metabolism in skeletal muscle 993
123
Jucker, B. M., Rennings, A. J. M., Cline, G. W., & Shulman, G. I.
(1997). C-13 and P-31 NMR studies on the effects of increased
plasma free fatty acids on intramuscular glucose metabolism in
the awake rat. Journal of Biological Chemistry, 272(16),
10464–10473.
Juel, C. (1991). Muscle lactate transport studied in sarcolemmal giant
vesicles. Biochimica et Biophysica Acta, 1065(1), 15–20. doi:10.
1016/0005-2736(91)90004-R.
Juel, C., & Halestrap, A. P. (1999). Lactate transport in skeletal
muscle—Role and regulation of the monocarboxylate trans-
porter. The Journal of Physiology, 517(3), 633–642. doi:10.
1111/j.1469-7793.1999.0633s.x.
Karl, I. E., Garber, A. J., & Kipnis, D. M. (1976). Alanine and
glutamine synthesis and release from skeletal-muscle. 3. Dietary
and hormonal-regulation. Journal of Biological Chemistry,
251(3), 844–850.
Kennedy, B. W. C., Kettunen, M. I., Hu, D. E., & Brindle, K. M.
(2012). Probing lactate dehydrogenase activity in tumors by
measuring hydrogen/deuterium exchange in hyperpolarized
L-[1-C-13, U-H-2]lactate. Journal of the American Chemical
Society, 134(10), 4969–4977. doi:10.1021/Ja300222e.
Kettunen, M. I., Hu, D. E., Witney, T. H., McLaughlin, R., Gallagher,
F. A., Bohndiek, S. E., et al. (2010). Magnetization transfer
measurements of exchange between hyperpolarized [1-C-
13]pyruvate and [1-C-13]lactate in a murine lymphoma. Mag-
netic Resonance in Medicine, 63(4), 872–880. doi:10.1002/Mrm.
22276.
Macdonald, M., Neufeldt, N., Park, B. N., Berger, M., & Ruderman,
N. (1976). Alanine metabolism and gluconeogenesis in rat.
American Journal of Physiology, 231(2), 619–626.
Mallette, L. E., Exton, J. H., & Park, C. R. (1969). Control of
gluconeogenesis from amino acids in perfused rat liver. Journal
of Biological Chemistry, 244(20), 5713–5723.
Mayer, D., Yen, Y. F., Josan, S., Park, J. M., Pfefferbaum, A., Hurd,
R. E., et al. (2012). Application of hyperpolarized [1-13C]lactate
for the in vivo investigation of cardiac metabolism. NMR in
Biomedicine, 25(10), 1119–1124. doi:10.1002/Nbm.2778.
Merritt, M. E., Harrison, C., Sherry, A. D., Malloy, C. R., & Burgess,
S. C. (2011). Flux through hepatic pyruvate carboxylase and
phosphoenolpyruvate carboxykinase detected by hyperpolarized
C-13 magnetic resonance. Proceedings of the National Academy
of Sciences of the United States of America, 108(47),
19084–19089. doi:10.1073/pnas.1111247108.
Merritt, M. E., Harrison, C., Storey, C., Jeffrey, F. M., Sherry, A. D.,
& Malloy, C. R. (2007). Hyperpolarized 13C allows a direct
measure of flux through a single enzyme-catalyzed step by
NMR. Proceedings of the National Academy of Sciences of the
United States of America, 104(50), 19773–19777. doi:10.1073/
pnas.0706235104.
Naressi, A., Couturier, C., Devos, J. M., Janssen, M., Mangeat, C., de
Beer, R., et al. (2001). Java-based graphical user interface for the
MRUI quantitation package. Magnetic Resonance Materials in
Physics, Biology and Medicine, 12(2–3), 141–152.
Odessey, R., Khairall, E. A., & Goldberg, A. L. (1974). Origin and
possible significance of alanine production by skeletal-muscle.
Journal of Biological Chemistry, 249(23), 7623–7629.
Pagliara, A. S., Kipnis, D. M., Karl, I. E., Devivo, D. C., & Feigin, R.
D. (1972). Hypoalaninemia—A concomitant of ketotic hypo-
glycemia. Journal of Clinical Investigation, 51(6), 1440–1449.
doi:10.1172/Jci106940.
Poole, R. C., & Halestrap, A. P. (1993). Transport of lactate and other
monocarboxylates across mammalian plasma-membranes. Amer-
ican Journal of Physiology, 264(4), C761–C782.
Roth, D. A. (1991). The sarcolemmal lactate transporter: Transmem-
brane determinants of lactate flux. Medicine and Science in
Sports and Exercise, 23(8), 925–934.
Ruderman, N. B., & Berger, M. (1974). Formation of glutamine and
alanine in skeletal-muscle. Journal of Biological Chemistry,
249(17), 5500–5506.
Schroeder, M. A., Cochlin, L. E., Heather, L. C., Clarke, K., Radda,
G. K., Tyler, D. J., et al. (2008). In vivo assessment of pyruvate
dehydrogenase flux in the heart using hyperpolarized carbon-13
magnetic resonance. Proceedings of the National Academy of
Sciences of the United States of America, 105(33), 12051–12056.
doi:10.1073/pnas.0805953105.
Vettor, R., Lombardi, A. M., Fabris, R., Pagano, C., Cusin, I.,
RohnerJeanrenaud, F., et al. (1997). Lactate infusion in
anesthetized rats produces insulin resistance in heart and skeletal
muscles. Metabolism-Clinical and Experimental, 46(6),
684–690. doi:10.1016/S0026-0495(97)90014-7.
Watt, P. W., Maclennan, P. A., Hundal, H. S., Kuret, C. M., &
Rennie, M. J. (1988). L(?)-lactate transport in perfused rat
skeletal-muscle: Kinetic characteristics and sensitivity to ph and
transport inhibitors. Biochimica et Biophysica Acta, 944(2),
213–222. doi:10.1016/0005-2736(88)90434-8.
Yoshida, Y., Holloway, G. P., Ljubicic, V., Hatta, H., Spriet, L. L.,
Hood, D. A., et al. (2007). Negligible direct lactate oxidation in
subsarcolemmal and intermyofibrillar mitochondria obtained
from red and white rat skeletal muscle. The Journal of
Physiology, 582(3), 1317–1335. doi:10.1113/jphysiol.2007.
135095.
994 J. A. M. Bastiaansen et al.
123
